Flip, Ah, I see you removed the second part of your original post. Smart move or you would've easily got caught in a lie.
I think they'll possibly submit something that we find requires a further submission based on another trial. It's their way. But this year...50/50. But then again, I put the odds of a JAMA retraction at 50/50.
"Tell me something, do you believe NWBO will submit an application for marketing approval this year?"
Market Data 
Markets 
AI
